EUVIMEDEUVIMED entdecken
Open Access

In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential

Huong Thi Luu Kim Huynh, Hendrick Gao-Min Lim, Yuan-Chii Gladys Lee, Thien-Vy Phan, Thanh-Hoa Vo, Chien-Hsin Chen, Alexander T H Wu

International Journal of Medical Sciences · 2025

DOI: 10.7150/ijms.105193 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Medical Sciences, 2025. Verfasst von Huong Thi Luu Kim Huynh und 6 weiteren Autor:innen. Beteiligte Einrichtung: International PhD Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pancreatic NeoplasmsHumansCell Line, TumorGene Expression Regulation, NeoplasticPrognosisTumor Suppressor Protein p53Computer SimulationCell ProliferationProto-Oncogene Proteins p21(ras)Biomarkers, TumorMutationMolecular Docking SimulationApoptosisAminopyridines

Stichwörter der Autor:innen

ANKRD22KRASbioinformaticsfostamatinibpancreatic cancer (PC)

Substanzen

Tumor Suppressor Protein p53TP53 protein, humanProto-Oncogene Proteins p21(ras)KRAS protein, humanBiomarkers, TumorAminopyridines

Autor:innen und Institutionen

  • International PhD Program for Translational Science, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Graduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
  • Department of Medical Research, Tzu Chi Hospital Indonesia, Pantai Indah Kapuk, Greater Jakarta, Indonesia 14470.
  • Department of Pharmacy, Nguyen Tat Thanh University, Ho Chi Minh City 700000, Vietnam.
  • University of Health Sciences, Vietnam National University Ho Chi Minh City, Ho Chi Minh City 700000, Vietnam.
  • Department of Surgery, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan.

Zitieren

APA

Huynh, H. T. L. K., Lim, H. G., Lee, Y. G., Phan, T. V., Vo, T. H., Chen, C. H., & Wu, A. T. H. (2025). In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential. International Journal of Medical Sciences. https://doi.org/10.7150/ijms.105193

Vancouver

Huynh HTLK, Lim HG, Lee YG, Phan TV, Vo TH, Chen CH, et al. In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential. International Journal of Medical Sciences. 2025. doi:10.7150/ijms.105193

BibTeX
@article{Huynh2025,
  author = {Huynh, Huong Thi Luu Kim and Lim, Hendrick Gao-Min and Lee, Yuan-Chii Gladys and Phan, Thien-Vy and Vo, Thanh-Hoa and Chen, Chien-Hsin and Wu, Alexander T H},
  title = {In Silico Identification of ANKRD22 as a Theragnostic Target for Pancreatic Cancer and Fostamatinib's Therapeutic Potential},
  journal = {International Journal of Medical Sciences},
  year = {2025},
  doi = {10.7150/ijms.105193}
}
Kostenlos starten →